Releases
-
Watch: Lab-to-Table Conversation: ‘Biomedical Research Ethics and the Scientific Method’
Join Hassane Mchaourab, the Louise B. McGavock Professor and professor of molecular physiology and biophysics, as he explores biomedical ethics with leading experts in law, biomedical research and basic sciences on Thursday, Sept. 29, from 11 a.m. to noon. Read MoreSep 20, 2022
-
How childhood trauma affects brain development and risk for incarceration: Virtual event Aug. 25
A Thursday, Aug. 25, discussion will connect how childhood trauma impacts brain development and behavior, its intersection with the justice system, and how we can integrate this understanding in prevention, diversion and restorative efforts. Read MoreAug 17, 2022
-
Filling multiple opioid prescriptions after childbirth associated with maternal death risk
In a new study led by Vanderbilt University Medical Center researchers, women who filled two or more prescriptions for opioids after childbirth faced a 46% greater risk of death than women who did not. Read MoreJun 9, 2022
-
Research probes cause of acute flaccid myelitis in children
Research that began at Vanderbilt University Medical Center has found evidence that a viral infection followed by a “robust” immune response is the cause of a polio-like paralyzing illness in children called acute flaccid myelitis (AFM). Read MoreJun 8, 2022
-
Moms who research moms: Spotlighting VU research on motherhood
They say motherhood is the toughest job you’ll ever love. That’s true for this group of Vanderbilt researchers, who’ve built successful careers around researching various aspects of parenthood while raising their own children. Read MoreMay 5, 2022
-
Additional COVID vaccine helps protect transplant patients
Additional booster doses of vaccine against COVID-19 are particularly important for those who are immunosuppressed, namely those who have had solid organ transplants, a new study shows. Read MoreApr 13, 2022
-
Vanderbilt Wond’ry opens new incubator space for startups affiliated with Nashville’s universities
The Wond’ry, Vanderbilt’s Center for Innovation, has opened an incubator space called Launch, which is dedicated to startup founders affiliated with local universities. Read MoreApr 5, 2022
-
Vanderbilt offers new climate studies major
The Vanderbilt College of Arts and Science has launched a new climate studies major. The major integrates the natural sciences, social sciences and humanities to give students a comprehensive perspective on climate change, its challenges and its possible solutions. Read MoreMar 30, 2022
-
Vanderbilt professional and graduate schools excel in 2023 ‘U.S. News’ rankings
Vanderbilt University’s graduate programs showed continued strength in the 2023 "U.S. News & World Report" Best Graduate Schools rankings, with five of Vanderbilt’s graduate and professional schools falling within the top 25. Read MoreMar 29, 2022
-
Vanderbilt inks collaboration with precision neuroscience company Neumora to continue development of investigational treatment for neuropsychiatric disorders
Vanderbilt University has signed an exclusive worldwide license and research collaboration agreement with Neumora Therapeutics, Inc., a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience. Read MoreFeb 22, 2022
-
Provost launching initiatives focused on research support, graduate education and more
Provost and Vice Chancellor for Academic Affairs C. Cybele Raver today announced six initiatives that include strengthening the university’s support of research, furthering connections and collaboration with Vanderbilt University Medical Center and further defining the future of graduate education. Read MoreFeb 10, 2022
-
Emeritus Professor of Chemistry Melvin Duane Joesten has died at 89
Melvin Duane Joesten, an emeritus chemistry professor and co-founder of Vanderbilt Student Volunteers for Science, died Jan. 17 in Nashville after a brief illness. He was 89. Read MoreFeb 4, 2022
-
CRISPR screen identifies new anti-inflammatory drug target
A novel CRISPR screen developed by Vanderbilt researchers identified a promising new target for anti-inflammatory therapeutics. Read MoreNov 11, 2021
-
Faculty Innovators: Sheila Ridner and Barbara Murphy spearhead trials for first at-home head and neck lymphedema treatment device
Vanderbilt professors Sheila Ridner and Barbara Murphy have contributed to the development of a first-of-its-kind device to treat head and neck lymphedema, a chronic disease common after cancer treatment that causes fluid buildup in the body and can complicate normal functions. Read MoreOct 6, 2021
-
Prediction models for breast cancer
Vanderbilt researchers developed new prognostic models for breast cancer outcomes and found that adding postdiagnostic weight change as a factor improves the prediction. Read MoreJul 27, 2021
-
Mood and cognition after chemotherapy
Validation of cognitive complaints appears to improve mood in patients with persistent chemotherapy-cognitive impairment, Vanderbilt researchers report. Read MoreJul 26, 2021
-
Ask an Expert: Do I need to get vaccinated even if I had COVID-19?
Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, shares why it's important for people to get vaccinated, even if they've already had COVID-19. Read MoreJul 15, 2021
-
Genetics of hydrocephalus
Fluid build-up in the brain — hydrocephalus — increases pressure and risk for brain damage; Vanderbilt researchers have now identified genes and signaling pathways associated with the condition. Read MoreJul 8, 2021
-
Vanderbilt Poll: Tennesseans split along party lines on vaccines, 2020 election and ‘cancel culture’
Divisive party politics continue to dominate attitudes among Tennessee residents on key social issues, including the state’s response to COVID-19, willingness to get vaccinated and questions about whether the 2020 presidential election was “stolen,” according to the latest Vanderbilt University poll. Read MoreJun 8, 2021
-
Vanderbilt researchers present new data on clinical trials at ASCO 2021
Vanderbilt-Ingram Cancer Center researchers will present data on clinical trials involving targeted therapies, immunotherapies and drug combination synergies at the 2021 American Society of Clinical Oncology Annual Meeting, June 4-8. The meeting is a virtual event this year. Read MoreMay 26, 2021